CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Methoxyflurane for Acute Pain: Clinical Effectiveness

Last updated: May 25, 2020
Project Number: RA1111-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the comparative clinical effectiveness of methoxyflurane versus inhaled nitrous oxide for acute pain?
  2. What is the clinical effectiveness of methoxyflurane for acute pain in pre-hospital or emergency department settings?

Key Message

One systematic review was identified regarding the comparative clinical effectiveness of methoxyflurane versus inhaled nitrous oxide for acute pain in the emergency setting.